Mankind Pharma Limited Return on Equity (ROE) for the year ending March 31, 2025: 13.89%

Mankind Pharma Limited Return on Equity (ROE) is 13.89% for the year ending March 31, 2025, a -32.01% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Mankind Pharma Limited Return on Equity (ROE) for the year ending March 31, 2024 was 20.43%, a 18.50% change year over year.
  • Mankind Pharma Limited Return on Equity (ROE) for the year ending March 31, 2023 was 17.24%, a -25.97% change year over year.
  • Mankind Pharma Limited Return on Equity (ROE) for the year ending March 31, 2022 was 23.29%, a -13.10% change year over year.
  • Mankind Pharma Limited Return on Equity (ROE) for the year ending March 31, 2021 was 26.80%, a -9.36% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share